The present research works carried out with the aim to prepare suspension dosage form using these microparticles for oral use. Solid Dosage forms are difficult for Pediatric, Geriatric patient & Dysphasic patients so for that patients the suspension dosage form more favorable than other solid dosage form. Albendazole drug has poor oral bioavailability (>5%) & a delayed release microspheric suspension of this drug would improve patient compliance & ease of swallowing. Microencapsulate facilitate the targeting of drug & mask the metallic taste of drug. The % yield was higher in the solvent...